£100.99

CRC Press Drug Development for Rare Diseases (Chapman & Hall/CRC Biostatistics Series)

Price data last checked 40 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£101 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 51 days · 51 data points (no recent data)

Historical
Generating forecast…
£133.08 £97.78 £105.48 £113.18 £120.89 £128.59 £136.29 24 May 2026 05 June 2026 18 June 2026 30 June 2026 13 July 2026

Price Distribution

Price distribution over 51 days • 2 price levels

Days at Price
Current Price
46 days · current 5 days 0 12 23 35 46 £101 £133 Days at Price

Price Analysis

Most common price: £101 (46 days, 90.2%)

Price range: £101 - £133

Price levels: 2 different prices over 51 days

Description

A disease is defined as rare if the prevalence is fewer than 200,000 in the United States. It is estimated that there are more than 7,000 rare diseases, which collectively affect 30 million Americans or 10% of the US population. This diverse and complex disease area poses challenges for patients, caregivers, regulators, drug developers, and other stakeholders. This book is proposed to give an overview of the common issues facing rare disease drug developers, summarize challenges specific to clinical development in small populations, discuss drug development strategies in the evolving regulatory environment, explain generation and utilization of different data and evidence inside and beyond clinical trials, and use recent examples to demonstrate these challenges and the development strategies that respond to the challenges. Key Features: • Rare disease. • Drug development. • Innovative clinical trial design. • Regulatory approval. • Real-world evidence.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
13 February 2023
Listed Since
12 July 2022

Barcode

No barcode data available

Similar Products You Might Like

Drug Development & Rare Pediatric Diseases: Issues, Strategic Plan, & Voucher Program Assessment (Pharmacology-research, Safety Testing and Regulation)
97% match

Drug Development & Rare Pediatric Diseases: Issues, Strategic Plan, & Voucher Program Assessment (Pharmacology-research, Safety Testing and Regulation)

£81.99 16 Jul 2026
Rare Diseases: Challenges and Opportunities for Social Entrepreneurs
97% match

Rare Diseases: Challenges and Opportunities for Social Entrepreneurs

Routledge

£37.22 16 Jul 2026
Communicating Rare Diseases and Disorders in the Digital Age (Advances in Medical Technologies and Clinical Practice)
96% match

Communicating Rare Diseases and Disorders in the Digital Age (Advances in Medical Technologies and Clinical Practice)

IGI Global

£308.56 19 Jun 2026
Springer Rare Diseases Epidemiology: Update and Overview 1031
95% match

Springer Rare Diseases Epidemiology: Update and Overview 1031

Springer

£140.34 04 Jul 2026
Orphan Drugs: Understanding the Rare Disease Market and Its Dynamics (Woodhead Publishing Series in Biomedicine)
95% match

Orphan Drugs: Understanding the Rare Disease Market and Its Dynamics (Woodhead Publishing Series in Biomedicine)

Woodhead Publishing

£110.00 15 Jul 2026
Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)
94% match

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£61.46 08 Jul 2026
Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)
94% match

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£80.00 14 Jul 2026
Global New Drug Development: An Introduction (ULLA Series in Pharmaceutical Sciences)
94% match

Global New Drug Development: An Introduction (ULLA Series in Pharmaceutical Sciences)

Wiley

£57.12 11 Jul 2026
Social Aspects of Drug Discovery, Development and Commercialization
94% match

Social Aspects of Drug Discovery, Development and Commercialization

Academic Press

£58.68 02 Jul 2026
Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)
94% match

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

£13.46 11 Jul 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)
94% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£85.00 09 Jul 2026
Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)
94% match

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£94.00 04 Jul 2026
Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)
94% match

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£142.00 26 Jun 2026
Rational Drug Design: Methods and Protocols: 928 (Methods in Molecular Biology, 928)
94% match

Rational Drug Design: Methods and Protocols: 928 (Methods in Molecular Biology, 928)

Humana

£84.79 06 Jul 2026
Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)
94% match

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Edward Elgar Publishing

£100.00 26 Jun 2026
Statistical Methods in Biomarker and Early Clinical Development
94% match

Statistical Methods in Biomarker and Early Clinical Development

Springer

£100.08 09 Jul 2026
Essentials of Translational Pediatric Drug Development: From Past Needs to Future Opportunities
94% match

Essentials of Translational Pediatric Drug Development: From Past Needs to Future Opportunities

Academic Press

£118.77 06 Jul 2026
Managing the Drug Discovery Process: Insights and advice for students, educators, and practitioners
94% match

Managing the Drug Discovery Process: Insights and advice for students, educators, and practitioners

Elsevier

£150.45 22 Aug 2026
Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)
94% match

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Springer

£118.93 03 Jul 2026
Ralph Edwards: RARE EVENTS: The Inside Story of a Worldwide Quest for Safer Medicines (Springer Biographies)
94% match

Ralph Edwards: RARE EVENTS: The Inside Story of a Worldwide Quest for Safer Medicines (Springer Biographies)

Springer

£81.66 30 Jul 2026
New Drug Development: An Introduction to Clinical Trials: Second Edition
94% match

New Drug Development: An Introduction to Clinical Trials: Second Edition

Springer

£214.00 19 Jun 2026
Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)
94% match

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£43.99 06 Jul 2026
Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens
94% match

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Springer

£49.10 12 Jul 2026